Table 2 Different expression of genes at the 4-week follow-up in stem cell treated patients compared to control patients
Accession number | Gene name | Affymetrix fold-expression | p value | Nanostring fold-expression | p value |
|---|---|---|---|---|---|
Macrophages, inflammation, and chemotaxis | |||||
NM_001040059, NM_001251 | CD68 CD68 molecule | 1.11 | 0.5874 | 5.19 | 0.0011 |
NM_002993 | CXCL6 (chemokine (C-X-C motif) ligand 6) | 2.03 | 0.0327 | 3.42 | 0.2015 |
NM_002985 | CCL5 (chemokine (C-C motif) ligand 5) | 1.53 | 0.0411 | – | – |
NM_033439 | IL33 (interleukin 33) | 1.53 | 0.0336 | – | – |
NM_000331, NM_001127380, NM_001178006, NM_030754, NM_199161 | SAA-1 (serum amyloid A1) | 1.73 | 0.0692 | 2.68 | 0.0455 |
NM_001127380, NM_030754 | SAA-2 (serum amyloid A2) | 1.12 | 0.7873 | 3.11 | 0.0202 |
NM_004887 | CXCL14 (chemokine (C-X-C motif) ligand 14) | –2.13 | 0.0458 | –6.32 | 0.1257 |
Liver regeneration and stem cells | |||||
NM_000601, NM_001010931, NM_001010932, NM_001010933, NM_001010934 | HGF (hepatocyte growth factor) | 1.11 | 0.4825 | 7.50 | 0.0019 |
NM_016639 | TNFRSF12A (tumor necrosis factor receptor superfamily, member 12A) | 1.15 | 0.4973 | 1.08 | 0.9551 |
NM_003122 | SPINK1 (serine peptidase inhibitor, Kazal type 1) | 4.29 | 0.0446 | 19.95 | 0.0979 |
NM_005556 | CK7(keratin 7) | –1.11 | 0.7284 | –3.38 | 0.3841 |
NM_002276 | CK19(keratin 19) | 1.04 | 0.8957 | –2.15 | 0.5533 |
NM_002838, NM_080921, NM_080923 | PTPRC (CD45) (protein tyrosine phosphatase, receptor type, C) | 1.52 | 0.0473 | 8.98 | 0.0260 |
Fibrosis | |||||
NM_000088 | COL1A1 (collagen, type I, alpha 1) | 1.38 | 0.1405 | 10.54 | 0.0101 |
Other | |||||
NM_001142466, NM_133443 | GPT2 | –1.54 | 0.0201 | – | – |
NM_001190463, NM_001902, NM_153742 | – | –1.83 | 0.0365 | – | – |
NM_001195728, NM_004171 | SLC1A2 (solute carrier family 1 (glial high affinity glutamate transporter), member 2) | –2.22 | 0.0147 | – | – |